Evaluating mobility issues in patients with chronic illnesses
Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort
This study is trying to understand how mobility issues affect people with chronic illnesses over five years to help create a better way to identify and care for those who struggle with movement.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 5000 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | University Hospital, Clermont-Ferrand Academic / other |
| Locations | 1 site (Clermont-Ferrand) |
| Trial ID | NCT04375280 on ClinicalTrials.gov |
What this trial studies
This study aims to create a prospective cohort of individuals suffering from chronic diseases to assess various aspects of mobility, including balance, muscle strength, body composition, and walking ability. By measuring these parameters at multiple time points over five years, the study seeks to identify interactions between these factors and their impact on functional capacity. The ultimate goal is to develop a screening algorithm that defines a 'dysmobility' profile, which could enhance the effectiveness of care for these patients. Statistical analyses will be conducted to determine patient profiles related to mobility issues.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 90 with chronic conditions that impair mobility.
Not a fit: Patients with progressive psychiatric disorders or unstable serious health conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved mobility and quality of life for patients with chronic illnesses.
How similar studies have performed: While the approach of profiling mobility in chronic illness is not widely tested, similar studies have shown promise in understanding mobility impairments.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Man or woman aged 18 to 90. * Patients with chronic pathology contributing to impaired mobility. * Volunteers who have given their written consent. * Affiliated to French health care system (for France) Exclusion Criteria: * Patients suffering from progressive psychiatric pathologies (active psychosis, hallucinations, etc.) or the presence of another serious unstabilized pathology (decompensated heart failure, progressive terminal cancer, etc.). * People with poorly controlled or unstable cardiovascular disease. * Major osteoarticular or neurological problems completely preventing the proper performance of the various tests. * Non-autonomous patient * Persons under guardianship, curatorship, deprived of liberty or safeguarding justice. * People excluded from another study. * Pregnant or lactating women.
Where this trial is running
Clermont-Ferrand
- Chu Clermont Ferrand — Clermont-Ferrand, France (Recruiting)
Study contacts
- Principal investigator: Frédéric Costes — University Hospital, Clermont-Ferrand
- Study coordinator: Lise Laclautre
- Email: promo_interne_drci@chu-clermontferrand.fr
- Phone: 334.73.754.963
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.